Braden Rosner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MCI Onehealth Announces Investment in Ariel Precision Medicine Investment further enables disease discovery and therapeutic development

Article content TORONTO, April 29, 2021 (GLOBE NEWSWIRE) MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, announces an initial investment in Ariel Precision Medicine, Inc. (“Ariel”) in exchange for a convertible promissory note that is convertible into equity securities in Ariel upon certain events. The investment supports the growth of Ariel while establishing a foundation for a collaborative commercial partnership and future entry for MCI into the United States market. With Ariel’s focus on precision diagnosis and targeted therapeutics, this investment is anticipated to advance MCI’s precision medicine and technology roadmap by accelerating both clinical and commercial projects with pharmaceutical, medical device and life sciences companies.

United statesFernando massalinBraden rosnerJessica gibsonAriel precision medicine incOnehealth technologies incGariel coAriel precision medicineAlexander dobranowskiஒன்றுபட்டது மாநிலங்களில்ஜெசிகா கிப்சன்

MCI Onehealth Completes Acquisition of Khure Health Khure s high growth revenue model will accelerate MCI Onehealth s roadmap toward becoming Canada s leader in precision medicine

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 27, 2021 (GLOBE NEWSWIRE) MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, has completed its previously announced acquisition of all the issued and outstanding shares (the “Transaction”) of Khure Health Inc. (“Khure”) pursuant to a share purchase agreement. Khure’s precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment. This strategic acquisition will enhance MCI’s data analytics offering through Khure’s continued work with leading pharmaceutical and medical device companies in North America, Europe and Japan.

United statesFernando massalinDon wattsBraden rosnerTransaction of khure health incOnehealth technologies incKhure healthNorth americaAlexander dobranowskiஒன்றுபட்டது மாநிலங்களில்தாதா வாட்ஸ்வடக்கு அமெரிக்கா

MCI Onehealth Announces Investment in and Commercial Support for Acorn Biolabs, Inc , Paving New Frontier in Precision Medicine

MCI Onehealth Announces Investment in and Commercial Support for Acorn Biolabs, Inc , Paving New Frontier in Precision Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alexander dobranowskiFernando massalinBraden rosnerOnehealth technologies incAcorn biolabs incWall streetAcorn biolabsDrew taylorInc acornReal venturesPool global partnersEpic capitalசுவர் தெருஈர்த்தது டெய்லர்இன்க் அகன்ரியல் முயற்சிகள்

MCI Onehealth Announces Partnership with Innovation and Personalized Care Leader, ReGen Scientific ReGen Co-Founder Dr Robert Francis to join MCI Onehealth Board of Advisors

Article content MCI Onehealth to offer commercial support in long-term partnership with ReGen, a leader in innovation and personalized, preventative, and regenerative health ReGen’s world-class logistics management and genetic testing laboratory will add another level of individualized healthcare to the MCI Onehealth ecosystem Partnership will further expand MCI Onehealth’s corporate health service offering and present the opportunity for an integrated client offering Precision health pioneer Dr. Robert Francis, Chairman and Co-Founder of ReGen and Medcan founder to join MCI Onehealth’s Board of Advisors MCI nominee to join ReGen’s Board of Directors TORONTO, April 12, 2021 (GLOBE NEWSWIRE) MCI Onehealth Technologies Inc. (“MCI Onehealth” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to, and quality of healthcare, has entered into a partnership with ReGen Scientific Inc. (“ReGen”), a leading per

Jean marc mackenzieAlexander dobranowskiFernando massalinRobert francisBraden rosnerOnehealth technologies incRegen scientific incCompany board of advisorsRegen scientificMedcan healthcareChief executive officerGen scientificஜீன் மார்க் மெக்கன்சிராபர்ட் பிரான்சிஸ்ரேகேன் அறிவியல் இன்க்ரேகேன் அறிவியல்

MCI Onehealth Announces Partnership with Innovation and Personalized Care Leader, ReGen Scientific

MCI Onehealth Announces Partnership with Innovation and Personalized Care Leader, ReGen Scientific ReGen Co-Founder Dr. Robert Francis to join MCI Onehealth Board of Advisors MCI Onehealth Technologies, Inc. Toronto, Ontario, CANADA MCI Onehealth to offer commercial support in long-term partnership with ReGen, a leader in innovation and personalized, preventative, and regenerative health ReGen’s world-class logistics management and genetic testing laboratory will add another level of individualized healthcare to the MCI Onehealth ecosystem Partnership will further expand MCI Onehealth’s corporate health service offering and present the opportunity for an integrated client offering Precision health pioneer Dr. Robert Francis, Chairman and Co-Founder of ReGen and Medcan founder to join MCI Onehealth’s Board of Advisors

Jean marc mackenzieAlexander dobranowskiFernando massalinRobert francisBraden rosnerOnehealth technologies incRegen scientific incCompany board of advisorsRegen scientificMedcan healthcareChief executive officerGen scientificToronto stock exchange drdrMci onehealth technologiesஜீன் மார்க் மெக்கன்சிராபர்ட் பிரான்சிஸ்